IR
Consolidated Financial Highlights
|
|
FY03/2021
|
FY03/2022
|
FY03/2023
|
FY03/2024
|
FY03/2025
|
|---|---|---|---|---|---|
|
Net sales
(Million Yen)
|
29,217
|
33,119
|
38,679
|
37,148
|
43,261
|
|
Operating profit
(Million Yen)
|
3,846
|
4,806
|
6,034
|
5,714
|
6,344
|
|
Ordinary profit
(Million Yen)
|
3,915
|
4,998
|
6,468
|
6,108
|
6,626
|
|
Net profit attributable to owners of parent
(Million Yen)
|
2,257
|
2,795
|
3,499
|
3,430
|
4,064
|
|
Total assets
(Million Yen)
|
38,683
|
42,975
|
51,011
|
55,185
|
58,375
|
|
Total net assets
(Million Yen)
|
27,756
|
31,529
|
35,578
|
39,943
|
44,406
|
|
Earnings per share
(Yen)
|
220.00
|
272.45
|
341.05
|
334.38
|
348.90
|
For the fiscal year ending March 2024 and before, the figures shown are for GL Sciences Inc. (consolidated) before the management integration.